Loading the section…

TGEN: financial statements from SEC — TradeAlmanac

TGEN

Tecogen Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	6M	7M	7M	7M	6M	5M
Cost of revenue	4M	5M	5M	4M	3M	3M
Gross profit	3M	2M	2M	3M	2M	2M
Research and development	363,823	297,926	268,724	292,668	233,809	246,489
Selling, general and administrative	4M	3M	3M	3M	3M	3M
Operating expenses	5M	4M	4M	4M	3M	4M
Operating income	−2M	−2M	−1M	−594,244	−873,223	−1M
Interest expense	—	—	—	—	—	17,869
Pre-tax income	−2M	−2M	−1M	−659,564	−895,930	−2M
Net income	−2M	−2M	−1M	−659,922	−930,408	−2M
Earnings per share	−0.07	−0.07	−0.06	−0.03	−0.04	−0.06
Earnings per share, diluted	−0.07	−0.07	−0.06	−0.03	−0.04	−0.06
Weighted average shares	30M	29M	25M	25M	25M	25M
Weighted average shares, diluted	30M	29M	25M	25M	25M	25M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	9M	12M	15M	2M	4M	5M	1M	841,913
Receivables	5M	4M	6M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−3M	−1M
Depreciation and amortisation	265,238	185,695
Share-based compensation	131,666	40,833
Capital expenditure	46,118	132,020
Investing cash flow	50,346	−164,909
Financing cash flow	−39,862

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator